Quest Diagnostics
DGX
$134.22
Share price
-0.99%
Change (1 day)
-1.19%
Change (1 year)
Categories
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Quest Diagnostics (DGX) - Total debt
Total debt on the balance sheet as of March 2023 : $4.62 B
According to Quest Diagnostics 's latest financial reports the company's total debt is $4.62 B. A company’s total debt is the sum of all current and non-current debts.
Quest Diagnostics - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $4.71 B | -1.24% |
| 2021-12-31 | $4.77 B | -0.73% |
| 2020-12-31 | $4.80 B | -11.23% |
| 2019-12-31 | $5.41 B | 35.71% |
| 2018-12-31 | $3.99 B | 3.53% |
| 2017-12-31 | $3.85 B | 3.24% |
| 2016-12-31 | $3.73 B | 2.27% |
| 2015-12-31 | $3.65 B | -2.95% |
| 2014-12-31 | $3.76 B | 12.91% |
| 2013-12-31 | $3.33 B | -0.94% |
| 2012-12-31 | $3.36 B | -16.43% |
| 2011-12-31 | $4.02 B | 34.61% |
| 2010-12-31 | $2.99 B | -3.77% |
| 2009-12-31 | $3.10 B | 0.78% |
| 2008-12-31 | $3.08 B | -12.92% |
| 2007-12-31 | $3.54 B | 127.56% |
| 2006-12-31 | $1.55 B | -2.28% |
| 2005-12-31 | $1.59 B | 44.9% |
| 2004-12-31 | $1.09 B | -0.35% |
| 2003-12-31 | $1.10 B | 34.06% |
| 2002-12-31 | $0.82 B | 0.1% |
| 2001-12-31 | $0.82 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 LabCorp LH | $6.29 B | 36.12% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | N/A | N/A | 🇺🇸 USA |
 Psychemedics PMD | $3.57 M | -99.92% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.61 B | -86.78% | 🇺🇸 USA |
 Qiagen QGEN | $1.86 B | -59.73% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $18.6 M | -99.60% | 🇺🇸 USA |